Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pereyra

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
Infection|September 9, 2022
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohortMario Karolyi, Andreas Gruebl, Sara Omid, et al.
Frontiers in Cardiovascular Medicine|December 3, 2021
Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5Huriye Ercan, Waltraud Cornelia Schrottmaier, Anita Pirabe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|January 27, 2026
ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Clinical Medicine|January 10, 2026
HTK Is a Viable UW Alternative for Hypothermic Oxygenated Machine Perfusion of Liver Grafts Supporting a Single-Solution ProtocolJule Dingfelder, David Pereyra, Moriz Riha, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
Hepatobiliary Surgery and Nutrition|February 10, 2025
Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failureMarkus Ammann, Jan Philipp Jonas, David Pereyra, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
Infection|September 9, 2022
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohortMario Karolyi, Andreas Gruebl, Sara Omid, et al.
Frontiers in Cardiovascular Medicine|December 3, 2021
Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5Huriye Ercan, Waltraud Cornelia Schrottmaier, Anita Pirabe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|January 27, 2026
ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Clinical Medicine|January 10, 2026
HTK Is a Viable UW Alternative for Hypothermic Oxygenated Machine Perfusion of Liver Grafts Supporting a Single-Solution ProtocolJule Dingfelder, David Pereyra, Moriz Riha, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
Hepatobiliary Surgery and Nutrition|February 10, 2025
Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failureMarkus Ammann, Jan Philipp Jonas, David Pereyra, et al.
Pageof 7